Zimmer Biomet (ZBH) Competitors

Zimmer Biomet (NYSE:ZBH) and Penumbra (NYSE:PEN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Is ZBH or PEN more profitable?

Penumbra has a net margin of 11.54% compared to Zimmer Biomet's net margin of 10.51%. Zimmer Biomet's return on equity of 12.76% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	10.51%	12.76%	7.21%
Penumbra	11.54%	11.55%	8.76%

Do insiders and institutionals hold more shares of ZBH or PEN?

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.4% of Zimmer Biomet shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Do analysts recommend ZBH or PEN?

Zimmer Biomet presently has a consensus price target of $111.94, suggesting a potential upside of 12.57%. Penumbra has a consensus price target of $302.81, suggesting a potential upside of 19.83%. Given Penumbra's stronger consensus rating and higher possible upside, analysts plainly believe Penumbra is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45
Penumbra	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.89

Does the media refer more to ZBH or PEN?

In the previous week, Zimmer Biomet had 9 more articles in the media than Penumbra. MarketBeat recorded 20 mentions for Zimmer Biomet and 11 mentions for Penumbra. Zimmer Biomet's average media sentiment score of 0.89 beat Penumbra's score of 0.52 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	12 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, ZBH or PEN?

Zimmer Biomet has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500.

Which has higher earnings & valuation, ZBH or PEN?

Zimmer Biomet has higher revenue and earnings than Penumbra. Zimmer Biomet is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.83B	2.51	$903.70M	$4.11	24.20
Penumbra	$1.19B	8.25	$14.01M	$3.76	67.21

Summary

Zimmer Biomet and Penumbra tied by winning 8 of the 16 factors compared between the two stocks.